EPRX
EPRX
NASDAQ · Biotechnology

Eupraxia Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$6.48
+0.19 (+3.02%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +584.3% upside
Low Target $25.23
Average Target $44.34
High Target $48.95
Current Price $6.48
Current
$6.48
Target
$44.34
$25.23 $44.34 avg $48.95
Scenario Analysis
Bear Case
$25.23
289.4%
Low target
Base Case
$44.34
+584.3%
Avg target
Bull Case
$48.95
+655.4%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$12.86
-49.6% from high
52-Week Low
$5.82
+11.3% from low
Target vs 52W High
$44.34
+244.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +5.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -46.4%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +191.5%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -36.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.5%